Skip to content
2000
Volume 17, Issue 11
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Background: Evidence has been provided of the anti-proliferative activity of citalopram against some cancer cells. Objective: The apoptotic impact of citalopram, an antidepressant, against liver hepatocellular carcinoma cell line HepG2 was investigated in relation to the oxidative pathway and nuclear factor (NF)ΚB activation. Method: The cytotoxic effects of citalopram on HepG2 cells were determined by MTT assay. Reactive oxygen species (ROS) formation and cytochrome c release were measured following treatment with citalopram. Apoptosis analysis and Bax and Bcl-­2 mRNA and protein levels were also determined. Results: The cytotoxic effects of different concentrations of citalopram on HepG2 cells were observed as a reduction in cell viability and an increase in ROS formation. Citalopram caused an increase in mitochondrial Bax levels and a decrease in Bcl2 levels and also caused cytochrome c release. Moreover, DAPI staining and flow cytometry assays revealed citalopram-induced apoptosis in HepG2 cells. Oxidant scavengers and Bay 11-7082 (an irreversible inhibitor of NFΚB activation) prevented the citalopram-associated cell death, increased BAX and decreased Bcl2. Conclusion: Outcomes from current study suggest that citalopram might exhibit apoptotic effect against hepatocellular carcinoma cell line by induction of cell death through cytochrome c release and ROS-dependent activation of NFΚB.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520617666170327155930
2017-10-01
2025-07-06
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520617666170327155930
Loading

  • Article Type:
    Research Article
Keyword(s): apoptosis; Bay11-7082; cancer; Citalopram; cytotoxicity; HepG2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test